논문번호 | 233 | ||
논문제목(영문) | Incidence of cardiac death and recurrent stent thrombosis after treatment for angiographically confirmed stent thrombosis | ||
국내외구분 | 국외 | SCI여부 | SCI |
연구책임자역할 | 교신저자 | ||
주저자명 | Min Chul Kim | ||
교신저자명 | Myung Ho Jeong | ||
공동저자명 | In-Soo Kim, Doo Sun Sim, Young Joon Hong, Ju Han Kim, Youngkeun Ahn, Jeong Gwan Cho, Jong Chun Park | ||
게제년월일 | 2019-09-01 | ||
ISSN | 0914-5087 | ||
Impact Factor | 2.246 | ||
학술지명 | JOURNAL OF CARDIOLOGY | ||
서지사항 | 0집 / 74권 / 3호, 페이지(267 - 272) | ||
요약초록문 (Abstract) 입력 |
Abstract Background: Although many studies showed the predictive factors of stent thrombosis (ST) occurrence, there are few data about clinical outcomes and recurrent ST after percutaneous coronary intervention (PCI) for ST. Furthermore, it is uncertain which factors can cause adverse clinical events including recurrent ST. Methods: This study examined the clinical outcomes after treatment for definite ST. Among 18,739 patients between June 2003 and December 2016 who underwent PCI using a drug-eluting stent (DES) or bare-metal stent (BMS), 243 consecutive patients who suffered definite ST were enrolled in this study. The overall incidence of ST was 1.3% (DES 1.4% and BMS 0.8%). The study endpoint was 1-year cardiac death or recurrent definite ST after the initial ST. Results: Study endpoint occurred in 57 patients (23.5%) during the 1-year follow-up after the initial ST. In multivariate analysis, the factors predicting 1-year endpoint were early ST [adjusted hazard ratio (HR): 2.23, 95% confidence interval (CI): 1.26-4.08, p=0.006], BMS ST (HR: 2.42, 95% CI: 1.27-4.81, p=0.045), serum level of glucose (HR: 1.03, 95% CI: 1.01-1.05, p=0.048), and ST-segment elevation myocardial infarction (STEMI) at the initial ST (HR: 3.73, 95% CI: 1.82-7.65, p<0.001). Conclusions: Recurrent ST or cardiac death during the first year after the initial ST event occurred in ∼25% of patients treated for definite ST. BMS ST, serum level of glucose, STEMI, and early ST at the initial ST were associated with adverse cardiac events. |
||
파일 |
C233. Incidence of cardiac death and recurrent stent thrombosis after treat~.pdf (508.2K) DATE : 2021-06-07 15:52:24 |
전라남도 장성군 남면 삼태리 산 109 나노바이오연구원 3층 306호 TEL : 061-392-6243 Fax: 061-392-6243
Copyright ⓒ 2014 Korea Cardiovascular Stent Research Institute. All right Reserved